Inspire Veterinary Partners, Inc. Class A (IVP) AI Stock Analysis

• Market Cap: $929.12K
• Dividend Yield: N/A
• Average Volume (3M): 44.35M
• Price to Earnings (P/E): ―
• Beta (1Y): 1.74
• Revenue Growth: -8.76%
• EPS Growth: 99.64%
• Country: US
• Employees: 113
• Sector: Consumer Cyclical
• Sector Strength: 84
• Industry: Personal Products & Services
• EPS (TTM): -0.41
• Shares Outstanding: 3,761,179
• 10 Day Avg. Volume: 132,839,515
• 30 Day Avg. Volume: 44,350,689
• PEG Ratio: <0.01
• Price to Book (P/B): 0.67
• Price to Sales (P/S): 0.06
• P/FCF Ratio: -0.10
• Enterprise Value/Market Cap: 21.71
• Enterprise Value/Revenue: 1.30
• Enterprise Value/Gross Profit: 4.26
• Enterprise Value/Ebitda: -2.41
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 37 Underperform
• Price Target: $0.00 ▼(-100.00% Downside)

Inspire Veterinary Partners, Inc. is facing substantial financial and market challenges. The company's high leverage, negative profitability, and weak market momentum are significant risks. The negative P/E ratio and lack of dividend yield further highlight financial difficulties. Immediate improvements in operational efficiency and debt reduction are essential for recovery.

Positive Factors

Revenue Sharing Agreements

Revenue sharing agreements provide a steady income stream and align incentives with partner clinics, supporting long-term revenue stability.

Partnerships with Pharmaceutical Companies

These partnerships enhance service offerings and streamline costs, strengthening IVP's competitive position in the veterinary services market.

Operational Support Services

Providing operational support services helps partner practices improve efficiency, fostering long-term client retention and revenue growth.

Negative Factors

High Leverage

High leverage can strain financial flexibility and increase risk, necessitating focus on debt reduction to stabilize the financial structure.

Negative Profitability

Persistent negative profitability affects cash generation and long-term sustainability, requiring operational improvements to enhance margins.

Declining Free Cash Flow

Declining free cash flow limits the company's ability to invest in growth opportunities and manage debt, impacting financial health.

Inspire Veterinary Partners, Inc. Class A Business Overview & Revenue Model

Company Description

Inspire Veterinary Partners, Inc. Class A (IVP) is a leading veterinary practice management company focused on providing high-quality veterinary care and services across the United States. The company partners with veterinary clinics and hospitals, offering them operational support, business management solutions, and access to advanced medical technologies. IVP's core services include veterinary practice acquisitions, operational consulting, and support for clinical staff, enabling partner practices to enhance their efficiency and improve patient care.

How the Company Makes Money

Inspire Veterinary Partners generates revenue primarily through a combination of service fees from partnered veterinary practices and a percentage of the profits from these practices. The company charges management fees for its operational support services, which may include marketing, financial management, and staff training. Additionally, IVP benefits from revenue sharing agreements, where it receives a portion of the profits from the veterinary clinics it partners with. Significant partnerships with pharmaceutical and pet care companies also contribute to its earnings through collaborative marketing efforts and supply chain agreements, allowing IVP to enhance its service offerings and streamline costs.

Inspire Veterinary Partners, Inc. Class A Financial Statement Overview

Summary

Inspire Veterinary Partners, Inc. faces significant challenges in profitability and financial stability. The company has high leverage, negative margins, and declining cash flows, which pose substantial risks. Improving operational efficiency and reducing debt are critical for enhancing financial performance.

Income Statement

Inspire Veterinary Partners, Inc. has shown a slight revenue growth in the TTM period, but profitability remains a concern with negative net profit and EBIT margins. The gross profit margin has decreased compared to the previous year, indicating pressure on cost management. The company needs to improve its operational efficiency to enhance profitability.

Balance Sheet

The balance sheet reveals a high debt-to-equity ratio, indicating significant leverage and potential financial risk. The negative return on equity highlights challenges in generating returns for shareholders. The equity ratio is low, suggesting reliance on debt financing. Improving equity and reducing debt could stabilize the financial structure.

Cash Flow

Cash flow analysis shows negative operating and free cash flows, with a declining free cash flow growth rate. However, the free cash flow to net income ratio is positive, indicating some efficiency in converting net income to cash. Enhancing cash flow generation is crucial for financial health.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	15.56M	16.59M	16.68M	9.83M	2.55M	0.00
Gross Profit	4.73M	3.29M	3.55M	2.55M	829.29K	0.00
EBITDA	-8.36M	-9.50M	-10.84M	-2.91M	-977.46K	0.00
Net Income	-11.94M	-14.26M	-14.79M	-4.91M	-1.33M	-5.52K
Balance Sheet
Total Assets	23.96M	20.20M	21.79M	20.19M	6.33M	21.97K
Cash, Cash Equivalents and Short-Term Investments	341.75K	523.69K	178.96K	444.25K	2.06M	21.97K
Total Debt	13.94M	16.37M	18.42M	23.61M	6.69M	0.00
Total Liabilities	19.79M	18.63M	22.58M	25.32M	7.20M	0.00
Stockholders Equity	4.17M	1.56M	-788.26K	-5.14M	-869.09K	21.97K
Cash Flow
Free Cash Flow	-4.34M	-10.24M	-4.20M	-2.84M	-2.32M	-5.52K
Operating Cash Flow	-4.23M	-10.01M	-3.82M	-2.66M	-1.01M	-5.52K
Investing Cash Flow	-1.96M	-237.98K	-1.87M	-14.67M	-4.02M	0.00
Financing Cash Flow	5.89M	10.59M	5.63M	15.71M	7.07M	269.16K

Inspire Veterinary Partners, Inc. Class A Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 0.12
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Positive
• RSI: Positive
• STOCH: Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IVP, the sentiment is Negative. The current price of 0.12 is below the 20-day moving average (MA) of 0.47, below the 50-day MA of 0.76, and below the 200-day MA of 1.24, indicating a bearish trend. The MACD of -0.20 indicates Positive momentum. The RSI at 20.94 is Positive, neither overbought nor oversold. The STOCH value of 6.76 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IVP.

Inspire Veterinary Partners, Inc. Class A Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
Sector *	61 Neutral	$18.38B	12.79	-2.54%	3.03%	1.52%	-15.83%
MRM	58 Neutral	$15.65M	5.41	48.22%	―	13.71%	―
XWEL	42 Neutral	$4.38M	―	―	―	-12.74%	13.22%
EJH	40 Neutral	$16.69M	-0.02	-1.75%	―	-2.53%	99.45%
IVP	37 Underperform	$929.12K	―	-331.80%	―	-8.76%	99.64%

Inspire Veterinary Partners, Inc. Class A Corporate Events

Inspire Veterinary Faces Nasdaq Delisting Threat

Inspire Veterinary Partners, Inc. has received a notice from Nasdaq indicating non-compliance with the minimum bid price requirement, threatening suspension and delisting of its securities. The company has requested a hearing, scheduled for January 13, 2026, to appeal this decision, but there is no assurance of a favorable outcome.

The most recent analyst rating on (IVP) stock is a Sell with a $0.50 price target. To see the full list of analyst forecasts on Inspire Veterinary Partners, Inc. Class A stock, see the IVP Stock Forecast page.

Inspire Veterinary Faces Nasdaq Delisting Notice

On November 13, 2025, Inspire Veterinary Partners, Inc. received a notice from Nasdaq indicating non-compliance with the minimum bid price requirement due to its stock’s performance over the past 30 days. As a result, the company’s securities are set to be suspended from trading on November 24, 2025, unless an appeal is requested by November 20, 2025. The company plans to appeal, which will delay the suspension or delisting process, but there is no guarantee of a favorable outcome.

The most recent analyst rating on (IVP) stock is a Sell with a $0.50 price target. To see the full list of analyst forecasts on Inspire Veterinary Partners, Inc. Class A stock, see the IVP Stock Forecast page.

Inspire Veterinary Partners Issues Convertible Notes for Capital

On November 5, 2025, Inspire Veterinary Partners, Inc. issued Senior Convertible Promissory Notes to Keystone Capital Partners, LLC and Seven Knots, LLC, each with a principal amount of $178,571.43. The notes, which mature on August 5, 2026, include a 10% annual interest rate and are convertible into the company’s Class A common stock. This financial maneuver is aimed at bolstering the company’s working capital, with specific terms allowing for conversion and prepayment under certain conditions, potentially impacting the company’s financial strategy and shareholder structure.

The most recent analyst rating on (IVP) stock is a Sell with a $0.50 price target. To see the full list of analyst forecasts on Inspire Veterinary Partners, Inc. Class A stock, see the IVP Stock Forecast page.

Inspire Veterinary Partners Expands Funding with New Investors

On September 9, 2025, Inspire Veterinary Partners, Inc. amended its securities purchase agreement to include new institutional investors for the issuance and sale of Series B convertible preferred stock and related warrants. This amendment resulted in an additional closing with 1,253 shares sold, generating approximately $1.0 million in gross proceeds, and was executed under exemptions from public offering registration, targeting accredited investors.

The most recent analyst rating on (IVP) stock is a Hold with a $1.00 price target. To see the full list of analyst forecasts on Inspire Veterinary Partners, Inc. Class A stock, see the IVP Stock Forecast page.

Inspire Veterinary Partners Regains Nasdaq Compliance

Inspire Veterinary Partners, Inc. announced on September 2, 2025, that it has regained compliance with Nasdaq’s Stockholders’ Equity Requirement after previously being notified on April 10, 2025, about non-compliance. The company received confirmation of compliance from Nasdaq on August 26, 2025, based on its Form 8-K filed with the SEC on August 20, 2025.

The most recent analyst rating on (IVP) stock is a Hold with a $1.00 price target. To see the full list of analyst forecasts on Inspire Veterinary Partners, Inc. Class A stock, see the IVP Stock Forecast page.